The Apple Watch helped define the modern smartwatch industry when it launched in 2015. It transformed wearables from niche gadgets into mainstream consumer products, generated billions in revenue for Apple, and eventually became a gateway into the company’s broader health and wearables ecosystem. But more than a decade later, Apple now appears to be entering a far more uncertain phase in the category it once dominated.
According to Mark Gurman’s PowerOn Bloomberg newsletter, watchOS 27 is expected to focus largely on stability improvements, performance refinements, and smaller upgrades rather than major new features. While Apple is reportedly improving heart-rate tracking behind the scenes, the update may lack the kind of headline innovations that once defined the Apple Watch platform.
Apple’s wearables strategy is facing new pressure
The slowdown comes as the broader wearables market is changing rapidly. Consumers are increasingly moving away from screen-heavy devices and toward simpler products focused on passive health tracking, longer battery life, and AI-driven wellness insights.
Companies like Oura Health and Whoop have built major businesses around screenless rings and fitness bands that prioritize recovery, sleep analysis, and actionable coaching over notifications and apps. Even Google is reportedly pushing toward lighter, minimalist wearable experiences through Fitbit products.
Apple still holds major advantages through its ecosystem integration, hardware design, and health sensors. But critics increasingly argue that the company risks becoming too cautious while rivals move faster in AI-powered health technology.
The issue may not only be hardware. Apple’s Health app, despite years of development, is often criticized for presenting large amounts of medical data without delivering meaningful insights or personalized coaching. Competitors like Oura and Whoop are increasingly focusing on turning raw health information into practical recommendations and behavioral guidance.
Leadership changes add more questions
Apple’s health division has also seen major leadership turnover. Former COO Jeff Williams, long associated with Apple’s health strategy, retired last year, while multiple senior executives tied to Apple Watch, health, and Fitness+ initiatives have recently departed the company.
Incoming CEO John Ternus is expected to keep health and AI central to Apple’s long-term roadmap, but many of the company’s more ambitious health projects remain years away. One of the most closely watched efforts is Apple’s noninvasive glucose monitoring project, which aims to measure blood sugar levels without finger pricks or blood draws.
For now, though, watchOS 27 may reflect a company choosing refinement over experimentation. That strategy helped Apple avoid many Silicon Valley-style missteps in the past. But in areas like AI and digital health, where competitors are evolving rapidly, playing it safe may no longer be enough.